Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SUDA Pharmaceuticals Announces Prospectus For Entitlement Offer (ASX:SUD)

Non-renounceable pro rata entitlement offer of 1 New Share for every 1 Existing Share (and 1 New Option for every 3 New Shares issued) at an offer price of $0.025 per New Share to raise approximatel...read more

SUDA Pharmaceuticals Announces Entitlement Offer To Raise Approximately $3.56 Million (ASX:SUD)

SUDA Pharmaceuticals Ltd (ASX: SUD), a leader in oromucosal drug delivery, is pleased to announce that it intends to conduct a 1 for 1 non-renounceable entitlement offer of fully paid ordinary share...read more

Reinstatement to Official Quotation (ASX:SUD)

For more information, please refer to the attached PDF

Market Update (ASX:SUD)

SUDA Pharmaceuticals Ltd (ASX: SUD), provides the following update in relation to the Company’s recent suspension. The Company had been progressing towards the announcement of a proposed mater...read more

Company Update and On Market Buy Back (ASX:SEQ)

For more information, please download the attached PDF

Sequoia Financial Group - Announcement of buy-back - Appendix 3C (ASX:SEQ)

To view the Announcement of buy-back (except minimum holding buy-back), download the attached PDF.

Sequoia Financial Group - Company Update and On Market Buy Back (ASX:SEQ)

Sequoia Financial Group Limited (ASX: SEQ) (Company or Sequoia) announces that further to the announcement lodged on 1 June 2020, in respect to adviser growth the Company can confirm that 22 of Phil...read more

SUDA Pharmaceuticals - Suspension from Official Quotation (ASX:SUD)

The securities of Suda Pharmaceuticals Ltd (‘SUD’) will be suspended from quotation immediately under Listing Rule 17.2, at the request of SUD, pending the release of an announcement reg...read more

Sequoia Financial Group - Change of Director's Interest Notice - Kevin Pattison (ASX:SEQ)

To view the Change of Director’s Interest Notice, download the attached PDF.

Change in substantial holding (ASX:SEQ)

For further information, please refer to the attached PDF

Sequoia Financial Growth - Further Adviser Growth (ASX:SEQ)

Sequoia Financial Group (Sequoia or SEQ) is pleased to announce it has entered in to a ‘Sale and Purchase of Assets Agreement’ with Phillip Capital Limited (PCL) that will see Sequoia We...read more

SUDA Pharmaceuticals - Pause in Trading (ASX:SUD)

Trading in the securities of the entity will be temporarily paused pending a further announcement. For more information, download the attached PDF.

Sequoia Financial Group - Trading Halt (ASX:SEQ)

The securities of Sequoia Financial Group Ltd (‘SEQ’) will be placed in trading halt at the request of SEQ, pending it releasing an announcement. Unless ASX decides otherwise, the securi...read more

Sequoia Financial Group - Pause in Trading (ASX:SEQ)

Trading in the securities of the entity will be temporarily paused pending a further announcement. For more information, download the attached PDF.

SUDA Pharmaceuticals Announces Anagrelide Cancer Patent For Japan (ASX:SUD)

SUDA Pharmaceuticals Ltd (ASX: SUD), a leader in oromucosal drug delivery, is pleased to announce that the Japanese Patent Office has now accepted the patent application and the patent will proceed ...read more

Viewing: 1 - 15 of 200 Previous | Next